Shares of Medline, a medical-supplies manufacturer and distributor, rose 41% in their trading debut Wednesday after the ...
Today, Dec. 18, 2025, a bullish analyst call spotlights Rivian’s R2 roadmap, autonomy push, and evolving EV strategy.
TipRanks on MSN
Rivian gets new Street high price target after Baird calls 2026 ‘the year of the R2’
Rivian’s ($RIVN) upcoming R2 launch, set for mid-2026, could be a major breakthrough for the electric vehicle maker. The R2 ...
Rivian expands hands-free driving to over 3.5 million miles with a major software update, adds new autonomy features and ...
Discover why RIVN is a Buy: strong balance sheet, new SaaS revenue, and growth prospects position it well for long-term ...
Jim Boyle, Medline CEO, celebrates with others as medical supplies giant Medline (MDLN) holds it's IPO at Nasdaq stock market ...
Shares are getting a boost from Baird’s upgrade as well as new features and updates for its R1 SUVs. The update to the ...
Rivian has just shared details of its latest over-the-air software update 2025.46, which includes some of the new features ...
Rivian Automotive, Inc. (NASDAQ:RIVN) shares are trading higher Thursday after Baird upgraded the stock from Neutral to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results